The traditional herbal medicine hochuekkito improves systemic inflammation in patients with chronic obstructive pulmonary disease [6]

Journal of the American Geriatrics Society

Volumn 55, Issue 2, 2007, Pages 313-314

  Shinozuka, Nariyuki ^a   Tatsumi, Koichiro ^a   Nakamura, Akira ^a   Terada, Jiro ^a   Kuriyama, Takayuki ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BRONCHODILATING AGENT; BU ZHONG YI QI TANG; C REACTIVE PROTEIN; INTERLEUKIN 6; PREALBUMIN; TUMOR NECROSIS FACTOR ALPHA;

AGED; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FORCED EXPIRATORY VOLUME; HERBAL MEDICINE; HUMAN; INFLAMMATION; LETTER; LUNG FUNCTION; PROSPECTIVE STUDY; RANDOMIZATION; TRADITIONAL MEDICINE;

ADMINISTRATION, ORAL; AGED; ANTI-INFLAMMATORY AGENTS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; DRUGS, CHINESE HERBAL; HUMANS; PHYTOTHERAPY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33846643547     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2007.01057.x     Document Type: Letter

References (7)

1. Tatsumi K, Sakao S, Igari H et al. Clinical phenotypes of chronic obstructive pulmonary disease: Results of a nationwide epidemiological survey in Japan. Respirology 2004;9:331-336.
2. Celli BR, Cote CG, Marin JM et al. The body mass index, airflow obstruction, dyspnea and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004;350:1005-1012.
3. Satoh N, Sakai S, Kogure Tet al. A randomized double blind placebo-controlled clinical trial of Hochuekkito, a traditional herbal medicine, in the treatment of elderly patients with weakness N of one and responder restricted design. Phytomedicine 2005;12:549-554.
4. Pinto-Plata VM, Müllerova H, Toso JF et al. C-reactive protein in patients with COPD, control smokers and non-smokers. Thorax 2006;61:23-28.
5. de Torres JP, Cordoba-Lanus E, Lopez-Aguilar C et al. C-reactive protein levels and clinically important predictive outcomes in stable COPD patients. Eur Respir J 2006;27:902-907.
6. Sin DD, Lacy P, York E et al. Effects of fluticasone on systemic markers of inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004;170:760-765.
7. Schols AM, Slangen J, Volovics L et al. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;157:1791-1797.